ASSESSING THE EFFICACY OF PARENTERAL IRON THERAPY IN TREATING PREGNANCY ANEMIA OF MILD TO MODERATE SEVERITY: A CLINICAL STUDY

Abstract

Background: A clinical disease known as anemia is defined by a reduction in the quantity of red blood cells or in their ability to deliver oxygen, which is necessary for bodily processes.

Aim: AThe purpose of this study was to evaluate the effectiveness of parenteral iron therapy in the management of mild to moderate cases of pregnant anemia. 

Methods: A total of 120 pregnant women with verified diagnoses of iron deficiency anemia were involved in this study. For three days, anti-helminthic medication and a dose of 100 mg mebendazole were administered twice a day to every subject that was included. Additionally, all of the subjects received folic acid during the therapy. All of the individuals underwent routine urine examination, culture, microscopy, renal function test (RFT), kidney function test (KFT), and stool examination for cyst and ovary.

Results: From baseline to follow-up, a number of hematologic markers revealed notable changes, according to the study's findings. The study's findings also showed a significant increase in mean hemoglobin values from baseline (7.28 gm to 11.28 gm). 

Conclusion: The current study shows that parenteral iron therapy is a useful treatment option for moderate to severe pregnant anemia, showing notable improvements in a number of parameters over time. As a result, it should be taken into consideration when treating iron deficiency.